Biomarin Pharmaceutical Inc. insider trading
This tab shows only the shares insiders bought or sold on the open market in the last twelve months (Form 4 codes P and S). Grants, option exercises, shares held back for tax and gifts are left out on purpose, so what is left is insiders trading at the market price like anyone else.
In the last twelve months insiders at Biomarin Pharmaceutical Inc. filed 5 open-market sales worth $4.3 million and 0 open-market purchases, on Form 4 with the SEC. The latest: Davis George Eric, EVP, Chief Legal Officer, sold 17,557 shares at $66.28 on 2 September 2026, filed 3 September 2026.
| Traded | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2 September 2026 | Davis George Eric | EVP, Chief Legal Officer | Sale | 17,557 | $66.28 | $1.2 million | Form 4 |
| 7 May 2026 | Friberg Gregory R | EVP, Chief R&D Officer | Sale | 3,281 | $53.85 | $176,682 | Form 4 |
| 11 March 2026 | Guyer Charles Greg | EVP, Chief Technical Officer | Sale | 16,486 | $60.46 | $996,744 | Form 4 |
| 26 February 2026 | Friberg Gregory R | EVP, Chief R&D Officer | Sale | 6,326 | $60.38 | $381,937 | Form 4 |
| 26 February 2026 | Davis George Eric | EVP, Chief Legal Officer | Sale | 26,061 | $61.36 | $1.6 million | Form 4 |
A filing with several lines appears once per line.
Source
Form 4 filings on EDGAR for Biomarin Pharmaceutical Inc.: the company's filing index.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.